Clinical TriAls
Wearables in Clinical Trials
Where we are & where we are going As real world evidence becomes an integral part for many clinical trials, wearables allow for monitoring and data collection anywhere the patient is located – freeing researchers of the location barrier of real world evidence. Xavier Flinois, President, PAREXEL Informatics
W
ith the demand for wearables and sensors in clinical trials on the rise, pharmaceutical companies are increasingly faced with the challenges of both rising costs and market saturation of similar drugs – and that is where Clinical Research Organisations (CROs) come into play. From both a technology perspective and a processes perspective, CROs can leverage remote medical devices, unleashing an opportunity to collect novel endpoints and supplemental data that may improve the regulatory case. This also opens the door for CROs to make the case for reimbursement more 36
P h a rm a F o c u s A s i a
ISSUE - 29 2017